A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
Article 2015 en
Authors
OC
Oriol Calvete
PM
Paula Martínez
PG
Pablo García‐Pavía
Abstract
1 min read
Abstract Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53 -negative Li–Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 ( protection of telomeres 1 ) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53 -negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121,324 studied alleles in ExAC server but it is not described in any other database or found in 1,520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.
Hester H. van Boven, Pieter H. Reitsma, Frits R. Rosendaal, Trevor A. Bayston, Vijoy Chowdhury, Jeanne‐Yvonne Borg, Kenneth A. Bauer, I. Scharrer, J. Conard, David A. Lane
Karin Wadt, Lauren G. Aoude, Peter A. Johansson, Annalisa Solinas, Antonia L. Pritchard, Oana Crainic, Morten Andersen, Jens Folke Kiilgaard, Steffen Heegaard, Lone Sunde, Birgitte Federspiel, Jason Madore, John F. Thompson, S. McCarthy, Annabel Goodwin, Hensin Tsao, Göran Jönsson, Klaus J. Busam, Ruta Gupta, Jeffrey M. Trent, Anne‐Marie Gerdes, Kevin M. Brown, ,
Discussion(0)
No comments yet. Be the first to comment.